Applied Genomic Technology Capital Fund Lp - Net Worth and Insider Trading

Applied Genomic Technology Capital Fund Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Applied Genomic Technology Capital Fund Lp owns 2 companies in total, including BG Medicine Inc (BGMD) , and Acceleron Pharma Inc (XLRN) .

Click here to see the complete history of Applied Genomic Technology Capital Fund Lp’s form 4 insider trades.

Insider Ownership Summary of Applied Genomic Technology Capital Fund Lp

Ticker	Comapny	Transaction Date	Type of Owner
BGMD	BG Medicine Inc	2015-07-27	10 percent owner
XLRN	Acceleron Pharma Inc	2013-09-18	10 percent owner

Applied Genomic Technology Capital Fund Lp Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Applied Genomic Technology Capital Fund Lp Ownership Network

Ownership Network List of Applied Genomic Technology Capital Fund Lp

No Data

Ownership Network Relation of Applied Genomic Technology Capital Fund Lp

Applied Genomic Technology Capital Fund Lp Owned Company Details

What does BG Medicine Inc do?

Who are the key executives at BG Medicine Inc?

Applied Genomic Technology Capital Fund Lp is the 10 percent owner of BG Medicine Inc. Other key executives at BG Medicine Inc include director & 10 percent owner Noubar Afeyan , 10 percent owner Flagship Pioneering Inc. , and 10 percent owner Agtc Advisors Fund Lp .

BG Medicine Inc (BGMD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of BG Medicine Inc (BGMD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BG Medicine Inc (BGMD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

BG Medicine Inc (BGMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

BG Medicine Inc Insider Transactions

No Available Data

Applied Genomic Technology Capital Fund Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Applied Genomic Technology Capital Fund Lp. You might contact Applied Genomic Technology Capital Fund Lp via mailing address: C/o Flagship Ventures One Memorial Drive, 7th Floor Cambridge Ma 02142.

Discussions on Applied Genomic Technology Capital Fund Lp

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.